Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19

Front Immunol. 2021 Jun 30:12:686029. doi: 10.3389/fimmu.2021.686029. eCollection 2021.

Abstract

More than one year since its emergence, corona virus disease 2019 (COVID-19) is still looming large with a paucity of treatment options. To add to this burden, a sizeable subset of patients who have recovered from acute COVID-19 infection have reported lingering symptoms, leading to significant disability and impairment of their daily life activities. These patients are considered to suffer from what has been termed as "chronic" or "long" COVID-19 or a form of post-acute sequelae of COVID-19, and patients experiencing this syndrome have been termed COVID-19 long-haulers. Despite recovery from infection, the persistence of atypical chronic symptoms, including extreme fatigue, shortness of breath, joint pains, brain fogs, anxiety and depression, that could last for months implies an underlying disease pathology that persist beyond the acute presentation of the disease. As opposed to the direct effects of the virus itself, the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is believed to be largely responsible for the appearance of these lasting symptoms, possibly through facilitating an ongoing inflammatory process. In this review, we hypothesize potential immunological mechanisms underlying these persistent and prolonged effects, and describe the multi-organ long-term manifestations of COVID-19.

Keywords: SARS-CoV-2; chronic COVID-19; clinical manifestations; immunopathology; long COVID-19; long-haulers; post-acute COVID-19 syndrome; post-acute sequelae of COVID-19.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anxiety / etiology
  • Arthralgia / etiology
  • Autoimmunity
  • COVID-19 / complications*
  • COVID-19 / epidemiology
  • COVID-19 / immunology
  • COVID-19 / virology
  • Depression / etiology
  • Dyspnea / etiology
  • Fatigue / etiology
  • Gastrointestinal Microbiome / immunology
  • Humans
  • Immunocompromised Host
  • Incidence
  • Post-Acute COVID-19 Syndrome
  • Prevalence
  • Renin-Angiotensin System / immunology
  • SARS-CoV-2 / immunology*